Singh, J. K., Farnie, G., Bundred, N. J., Simões, B. M., Shergill, A., Landberg, G., . . . Clarke, R. B. (2012). Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-dependent and -independent Mechanisms. Clin Cancer Res.
Citação norma ChicagoSingh, Jagdeep K., Gillian Farnie, Nigel J. Bundred, Bruno M. Simões, Amrita Shergill, Göran Landberg, Sacha Howell, and Robert B. Clarke. "Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 Via HER2-dependent and -independent Mechanisms." Clin Cancer Res 2012.
ציטוט MLASingh, Jagdeep K., et al. "Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 Via HER2-dependent and -independent Mechanisms." Clin Cancer Res 2012.